150 related articles for article (PubMed ID: 37654999)
1. Clinical evaluation of a topical Unani pharmacopoeial formulation
Salma ; Shamsi Y; Nikhat S; Manjhi M; Akhtar MW; Ahmad S
Avicenna J Phytomed; 2023; 13(3):255-264. PubMed ID: 37654999
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled clinical trial to evaluate safety and efficacy of a Unani formulation in the management of Kalaf (Melasma).
Qaiyyum IA; Nawab M; Kazmi MH
J Complement Integr Med; 2023 Mar; 20(1):233-240. PubMed ID: 34582636
[TBL] [Abstract][Full Text] [Related]
3. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
Adalatkhah H; Sadeghi-Bazargani H
Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
[TBL] [Abstract][Full Text] [Related]
4. Pigmentation control in pregnancy-induced melasma: Clinical assessment of a non-hydroquinone, non-retinol pigment-correcting serum.
Makino ET; Jiang LI; Stephens TJ; Mikati M; Mehta RC
J Cosmet Dermatol; 2022 Nov; 21(11):5739-5746. PubMed ID: 35708506
[TBL] [Abstract][Full Text] [Related]
5. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
Basit A; Rahman A; Uddin R
J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
[TBL] [Abstract][Full Text] [Related]
6. Clinical Efficacy and Safety on Combining 20% Trichloroacetic Acid Peel with Topical 5% Ascorbic Acid for Melasma.
Dayal S; Sahu P; Yadav M; Jain VK
J Clin Diagn Res; 2017 Sep; 11(9):WC08-WC11. PubMed ID: 29207818
[TBL] [Abstract][Full Text] [Related]
7. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
Grimes PE
Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
Mendoza CG; Singzon IA; Handog EB
Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
[TBL] [Abstract][Full Text] [Related]
9. Interventions for melasma.
Rajaratnam R; Halpern J; Salim A; Emmett C
Cochrane Database Syst Rev; 2010 Jul; (7):CD003583. PubMed ID: 20614435
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial.
Lima PB; Dias JAF; Cassiano DP; Esposito ACC; Miot LDB; Bagatin E; Miot HA
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1881-1887. PubMed ID: 33988887
[TBL] [Abstract][Full Text] [Related]
11. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
Rivas S; Pandya AG
Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study.
Tehranchinia Z; Saghi B; Rahimi H
Dermatol Res Pract; 2018; 2018():8350317. PubMed ID: 30079087
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
[TBL] [Abstract][Full Text] [Related]
14. Intradermal Injection of 100mg Tranexamic Acid Versus Topical 4% Hydroquinone for the Treatment of Melasma: A Randomized, Controlled Trial.
Pazyar N; Dezfuly MB; Hadibarhaghtalab M; Parvar SY; Molavi SN; Mapar MA; Zeinali M
J Clin Aesthet Dermatol; 2023 Jan; 16(1):35-40. PubMed ID: 36743976
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial.
Gheisari M; Dadkhahfar S; Olamaei E; Moghimi HR; Niknejad N; Najar Nobari N
J Cosmet Dermatol; 2020 Jan; 19(1):167-172. PubMed ID: 31102345
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Study of the Efficacy of 4% Hydroquinone vs 0.75% Kojic Acid Cream in the Treatment of Facial Melasma.
Monteiro RC; Kishore BN; Bhat RM; Sukumar D; Martis J; Ganesh HK
Indian J Dermatol; 2013 Mar; 58(2):157. PubMed ID: 23716817
[TBL] [Abstract][Full Text] [Related]
17. A pilot study using reflectance confocal microscopy (RCM) in the assessment of a novel formulation for the treatment of melasma.
Tsilika K; Levy JL; Kang HY; Duteil L; Khemis A; Hughes R; Passeron T; Ortonne JP; Bahadoran P
J Drugs Dermatol; 2011 Nov; 10(11):1260-4. PubMed ID: 22052305
[TBL] [Abstract][Full Text] [Related]
18. Kojic Acid vis-a-vis its Combinations with Hydroquinone and Betamethasone Valerate in Melasma: A Randomized, Single Blind, Comparative Study of Efficacy and Safety.
Deo KS; Dash KN; Sharma YK; Virmani NC; Oberai C
Indian J Dermatol; 2013 Jul; 58(4):281-5. PubMed ID: 23918998
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
[TBL] [Abstract][Full Text] [Related]
20. Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study.
Tekam PS; Belgaumkar VA
Dermatol Ther; 2022 Nov; 35(11):e15761. PubMed ID: 36068674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
